The company plans to launch Sol in 2027 and Apollo in 2029, targeting commercially viable quantum applications. Quantinuum reported a $192.6 million net loss and approximately $263 million free cash ...

Considering a total event rate (for the primary endpoint) of 30% at 48 hours in the clopidogrel arm our hypothesis was a 20 % relative risk reduction of the primary endpoint (80% power, two-sided ...

A metadata commons to store research software metadata - arash77/research-software-ecosystem-content ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...